Ideas to action: independent research for global prosperity
Search
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
November 03, 2016
Having tried and mostly failed to track what was going on with US Government performance and spending on Ebola, I welcome the GAO’s overview of obligations and disbursements by appropriation account and strategy pillar. Now the scope of this report appears to be narrow, so let’s hope there’s more to...
Blog Post
September 26, 2016
Zika’s rapid spread has focused media attention on how poorly prepared both rich and less rich countries are for infectious disease outbreaks. And while it seems that we are still flailing, in fact, the international community has been trying to do better for a while. Perhaps the most sign...
Blog Post
June 28, 2016
From the superbug scare in Pennsylvania last month to the UK’s recently released Review on Antimicrobial Resistance, slowing the rate at which infections become resistant to antibiotics is rising up the list of global health priorities—and rightfully so. The Review estimates that deat...
Multimedia
June 08, 2016
Antimicrobial resistance (AMR) threatens future growth and prosperity, as well as health. Without global action, the UK's Review on Antimicrobial Resistance, led by Lord Jim O'Neill, estimates that an additional 10 million people will die every year from drug-resistant infections and the global econ...
TESTIMONY
April 08, 2016
On April 7, 2016, CGD’s vice president for programs and director of global health policy Amanda Glassman testified before the Senate Foreign Relations Subcommittee on Africa and Global Health Policy at a hearing examining progress made in addressing the West Africa Ebola epidemic and its s...